2021 Q3 Form 10-Q Financial Statement

#000126246321000441 Filed on September 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.350K $2.847K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.350K $2.847K
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.350K -$2.850K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$9.347K -$2.847K
YoY Change -56.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$136.80 -$41.70
COMMON SHARES
Basic Shares Outstanding 68.35M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $960.00 $822.00 $0.00
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.660K $33.67K $25.64K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.660K $33.67K $25.64K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.660K $33.67K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$10.05M -$10.04M
YoY Change
Common Stock $68.35K $68.35K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.656K -$33.67K -$25.64K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q4
OPERATING ACTIVITIES
Net Income -$9.347K -$2.847K
YoY Change -56.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.210K -$7.210K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.210K 7.210K
YoY Change
NET CHANGE
Cash From Operating Activities -9.210K -7.210K
Cash From Investing Activities
Cash From Financing Activities 9.210K 7.210K
Net Change In Cash 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$9.210K -$7.210K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Assets Current
AssetsCurrent
0 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q2 us-gaap Assets
Assets
0 USD
CY2020Q4 us-gaap Assets
Assets
0 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
822 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68346042 shares
CY2021Q2 us-gaap Cash
Cash
0 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
32848 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2847 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25640 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5183 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-30823 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2847 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-33670 USD
us-gaap Net Income Loss
NetIncomeLoss
-8030 USD
us-gaap Net Income Loss
NetIncomeLoss
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
822 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7208 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7208 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7208 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
25640 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33670 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25640 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
10000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68346042 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
68346 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
68346 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9939684 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9939684 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10051700 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10043670 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-33670 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25640 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q2 us-gaap Revenues
Revenues
0 USD
CY2020Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2021Q2 hraa Total Revenue
TotalRevenue
0 USD
CY2020Q2 hraa Total Revenue
TotalRevenue
0 USD
hraa Total Revenue
TotalRevenue
0 USD
hraa Total Revenue
TotalRevenue
0 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8030 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
0 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2847 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
0 USD
us-gaap Operating Expenses
OperatingExpenses
8030 USD
us-gaap Operating Expenses
OperatingExpenses
0 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2847 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-8030 USD
us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68346042 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68346042 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68346042 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68346042 shares
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2019Q4 us-gaap Cash
Cash
0 USD
CY2021Q2 us-gaap Cash
Cash
0 USD
CY2020Q2 us-gaap Cash
Cash
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Each share of HRAA’s common stock was exchanged for the right to receive approximately 1,271 shares of HRAH’s common stock
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68346042 shares
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10051700 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p>

Files In Submission

Name View Source Status
0001262463-21-000441-index-headers.html Edgar Link pending
0001262463-21-000441-index.html Edgar Link pending
0001262463-21-000441.txt Edgar Link pending
0001262463-21-000441-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hraa-20210630.xsd Edgar Link pending
hraa-20210630_cal.xml Edgar Link unprocessable
hraa-20210630_def.xml Edgar Link unprocessable
hraa-20210630_lab.xml Edgar Link unprocessable
hraa-20210630_pre.xml Edgar Link unprocessable
hraa63021q.htm Edgar Link pending
hraa63021q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending